natgillin/translations-raw huggingface dataset:
One vial of 5 ml contains 50 mg brivaracetam. 
Ena viala po 5 ml vsebuje 50 mg brivaracetama.
10 ml oral dosing syringe 
10-ml peroralna odmerna brizga
Children (≥4 years) and adolescents <50 kg 
Otroci (≥ 4 leta) in mladostniki < 50 kg odmerja se razdeljen na 2 enaka odmerka
What Briviact contains The active substance is brivaracetam. 
Kaj vsebuje zdravilo Briviact Zdravilna učinkovina je brivaracetam.
Briviact 75 mg are purple, oval, film-coated tablets of 13.0 mm x 7.3 mm and debossed with ‘u75' on one side. 
Tablete zdravila Briviact 75 mg so škrlatne, ovalne, filmsko obložene tablete z dimenzijami 13,0 mm x 7,3 mm in vtisnjeno oznako u75 na eni strani.
Do not use this medicine after the expiry date which is stated on the carton and vial after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli ali viali poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
Green-grey, oval film-coated tablets with dimensions of 14.5 mm x 8.1 mm and debossed with ‘u100' on one side. 
Zelenosive, ovalne, filmsko obložene tablete z dimenzijami 14,5 mm x 8,1 mm in vtisnjeno oznako u100 na eni strani.
Briviact 75 mg film-coated tablets Each film-coated tablet contains 75 mg brivaracetam. 
Briviact 75 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 75 mg brivaracetama.
White to off-white, round film-coated tablets of 6.5 mm in diameter and debossed with ‘u10' on one side. 
Bele do umazano bele, okrogle, filmsko obložene tablete s premerom 6,5 mm in vtisnjeno oznako u10
Grey, oval film-coated tablets with dimensions of 8.9 mm x 5.0 mm and debossed with ‘u25' on one side. 
Sive, ovalne, filmsko obložene tablete z dimenzijami 8,9 mm x 5,0 mm in vtisnjeno oznako u25 na eni strani.
Children (from 4 years of age) and adolescents weighing 50 kg or more 
Odrasli, mladostniki in otroci, ki tehtajo 50 kg ali več
Briviact 25 mg are grey, oval, film-coated tablets of 8.9 mm x 5.0 mm and debossed with ‘u25' on one side. 
Tablete zdravila Briviact 25 mg so sive, ovalne, filmsko obložene tablete z dimenzijami 8,9 mm x 5,0 mm in vtisnjeno oznako u25 na eni strani.
Briviact 10 mg/ml solution for injection/infusion 
Briviact 10 mg/ml raztopina za injiciranje/infundiranje
(corresponding to 2 mg/kg/intake) 
(ustreza 2 mg/kg/vnos)
Briviact 75 mg film-coated tablets 
Briviact 75 mg filmsko obložene tablete
Croscarmellose Sodium, Lactose monohydrate Betadex 
6.1 Seznam pomožnih snovi Jedro premrežen natrijev karmelozat laktoza monohidrat betadeks brezvodna laktoza magnezijev stearat
0.05 ml/kg/intake 
0,05 ml/kg/vnos
Brivaracetam oral solution contains sodium. 
Peroralna raztopina brivaracetama vsebuje natrij.
Zonisamide 
Nič zonisamid
Yellow, oval film-coated tablets with dimensions of 11.7 mm x 6.6 mm and debossed with ‘u50' on one side. 
Rumene, ovalne, filmsko obložene tablete z dimenzijami 11,7 mm x 6,6 mm in vtisnjeno oznako u50 na eni strani.
Briviact 50 mg are yellow, oval, film-coated tablets of 11.7 mm x 6.6 mm and debossed with ‘u50' on one side. 
Tablete zdravila Briviact 50 mg so rumene, ovalne, filmsko obložene tablete z dimenzijami 11,7 mm x 6,6 mm in vtisnjeno oznako u50 na eni strani.
0.1 ml/kg/intake 
0,1 ml/kg/vnos
Briviact 100 mg film-coated tablets Each film-coated tablet contains 100 mg brivaracetam. 
Briviact 100 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 100 mg brivaracetama.
Not Applicable. 
Navedba smiselno ni potrebna.
Briviact contains the active substance brivaracetam. 
Zdravilo Briviact vsebuje zdravilno učinkovino brivaracetam.
Volume per administration (ml) = [weight (kg) x daily dose (mg/kg/day) ] x 0.05 
Količina na dajanje (ml) = [telesna masa (kg) x dnevni odmerek (mg/kg/dan)] x 0,05 V spodnji preglednici so količine za peroralno raztopino na vnos, odvisne od predpisanega odmerka in telesne mase.
Somnolence and dizziness have been reported in a healthy subject taking a single dose of 1,400 mg of brivaracetam. 
Pri zdravih preskušancih, ki so vzeli enojni odmerek 1400 mg brivaracetama, so poročali o somnolenci in omotici.
nervous excitement (agitation) - thoughts or attempts of harming or killing yourself: tell your doctor straight away - a decrease in white blood cells (called ‘neutropenia') - shown in blood tests 
Občasni: pojavijo se lahko pri največ 1 od 100 bolnikov - alergijske reakcije - nenormalne misli in/ali izguba stika z realnostjo (psihotične motnje), agresivnost, motorični nemir (agitacija) - misli ali poskusi o samopoškodovanju ali samomoru: to takoj povejte zdravniku - zmanjšanje števila belih krvnih celic (nevtropenija), ki ga pokažejo krvni testi
Briviact 10 mg film-coated tablets Polyvinyl alcohol Titanium dioxide (E171) Macrogol 3350 
Briviact 10 mg filmsko obložene tablete polivinilalkohol titanov dioksid (E171) makrogol 3350 smukec
In all controlled and uncontrolled trials in patients with epilepsy, 2,388 subjects have received brivaracetam, of whom 1,740 have been treated for ≥ 6 months,1,363 for ≥ 12 months, 923 for ≥ 24 months and 569 for ≥ 60 months (5 years). 
Od teh je bilo 1740 zdravljenih ≥ 6 mesecev, 1363 ≥ 12 mesecev, 923 ≥ 24 mesecev in 569 ≥ 60 mesecev (5 let).
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli ali pretisnem omotu poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
A meta-analysis of randomized placebocontrolled trials of AEDs has also shown a small increased risk of suicidal ideation and behaviour. 
Majhno povečanje tveganja za pojav samomorilnega razmišljanja in vedenja je pokazala tudi metaanaliza randomiziranih, s placebom nadzorovanih preskušanj antiepileptikov.
Each film-coated tablet contains 75 mg brivaracetam. 
Ena filmsko obložena tableta vsebuje 75 mg brivaracetama.
Briviact 25 mg film-coated tablets Each film-coated tablet contains 25 mg brivaracetam. 
Briviact 25 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 25 mg brivaracetama.
Purple, oval film-coated tablets with dimensions of 13.0 mm x 7.3 mm debossed with ‘u75' on one side. 
Škrlatne, ovalne, filmsko obložene tablete z dimenzijami 13,0 mm x 7,3 mm in vtisnjeno oznako u75 na eni strani.
Dose adjustments are recommended for patients with hepatic impairment (see section 
Za bolnike z okvaro jeter je priporočena prilagoditev odmerka (glejte poglavje 4.2).
(corresponding to 1 mg/kg/intake) 
(ustreza 1 mg/kg/vnos)
Briviact 25 mg film-coated tablets 
Briviact 25 mg filmsko obložene tablete
For a dose of 1 mg/kg/day 
Za odmerek 1 mg/kg/dan
0.5 mg/kg = 0.05 ml/kg 
Telesna masa 0,5 mg/kg = 0,05 ml/kg
0.15 ml/kg/intake 
0,15 ml/kg/vnos
Briviact 10 mg/ml solution for injection/infusion brivaracetam 
Briviact 10 mg/ml raztopina za injiciranje/infundiranje brivaracetam
Briviact 100 mg film-coated tablets 
Briviact 100 mg filmsko obložene tablete
Briviact 10 mg film-coated tablets 
Briviact 10 mg filmsko obložene tablete
For a dose of 4 mg/kg/day 
Za odmerek 4 mg/kg/dan
Lamotrigine 
Obloga
Briviact 50 mg film-coated tablets Each film-coated tablet contains 50 mg brivaracetam. 
Briviact 50 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 50 mg brivaracetama.
The estimated plasma clearance was 1.61 L/h, 2.18 L/h and 3.19 L/h for children weighing 20 kg, 30 kg and 50 kg, respectively. 
Modeliranje populacijske farmakokinetike je pokazalo, da je odmerek 2,0 mg/kg dvakrat na dan povzročil enako povprečno plazemsko koncentracijo v dinamičnem ravnovesju kot pri odraslih, ki so prejemali 100 mg dvakrat na dan. Ocenjeni plazemski očistek je bil 1,61 l/uro za otroke, ki so tehtali 20 kg, 2,18 l/uro za otroke, ki so tehtali 30 kg in 3,19 l/uro za otroke, ki so tehtali 50 kg. Za primerjavo je bil ocenjeni plazemski očistek za odrasle bolnike 3,58 l/uro (70 kg telesne mase).
Each film-coated tablet contains 25 mg brivaracetam. 
Ena filmsko obložena tableta vsebuje 25 mg brivaracetama.
- If you are not sure what to do, ask your doctor or pharmacist. 
- Če ste negotovi, se posvetujte z zdravnikom ali farmacevtom.
Each film-coated tablet contains 10 mg brivaracetam. 
Ena filmsko obložena tableta vsebuje 10 mg brivaracetama.
Each film-coated tablet contains 100 mg brivaracetam. 
Ena filmsko obložena tableta vsebuje 100 mg brivaracetama.
Briviact 50 mg film-coated tablets 
Briviact 50 mg filmsko obložene tablete
0.2 ml/kg/intake 
0,2 ml/kg/vnos
Briviact 10 mg/ml oral solution brivaracetam 
Briviact 10 mg/ml peroralna raztopina brivaracetam
For a dose of 2 mg/kg/day 
Za odmerek 2 mg/kg/dan
Briviact 75 mg film-coated tablets brivaracetam 
Briviact 75 mg filmsko obložene tablete brivaracetam
Strong enzyme inducing AEDs 
Antiepileptiki, ki močno inducirajo encime
For a dose of 3 mg/kg/day 
Za odmerek 3 mg/kg/dan
Each film-coated tablet contains 50 mg brivaracetam. 
Ena filmsko obložena tableta vsebuje 50 mg brivaracetama.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING AND IMMEDIATE PACKAGING 
Izgled zdravila Briviact in vsebina pakiranja
Briviact 100 mg film-coated tablets brivaracetam 
Briviact 100 mg filmsko obložene tablete brivaracetam
Briviact 10 mg film-coated tablets brivaracetam 
Briviact 10 mg filmsko obložene tablete brivaracetam
Briviact 25 mg film-coated tablets brivaracetam 
Briviact 25 mg filmsko obložene tablete brivaracetam
EU/1/15/1073/017 14 film-coated tablets EU/1/15/1073/018 56 film-coated tablets EU/1/15/1073/019 100 x 1 film-coated tablet EU/1/15/1073/027 14 x 1 film-coated tablet 
EU/1/15/1073/017 14 filmsko obloženih tablet EU/1/15/1073/018 56 filmsko obloženih tablet EU/1/15/1073/019 100 x 1 filmsko obložena tableta EU/1/15/1073/027 14 x 1 filmsko obložena tableta
Briviact is a long term treatment - keep taking Briviact until your doctor tells you to stop. 
Jemljite ga, dokler vam zdravnik ne naroči, da prenehajte.
Clobazam 
klobazam
Phenytoin 
Nič fenitoin
Briviact 50 mg film-coated tablets brivaracetam 
Briviact 50 mg filmsko obložene tablete brivaracetam
EU/1/15/1073/004 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/004 168 (3 pakiranja po 56) filmsko obloženih tablet
EU/1/15/1073/013 14 film-coated tablets EU/1/15/1073/014 56 film-coated tablets EU/1/15/1073/015 100 x 1 film-coated tablet EU/1/15/1073/026 14 x 1 film-coated tablet 
EU/1/15/1073/013 14 filmsko obloženih tablet EU/1/15/1073/014 56 filmsko obloženih tablet EU/1/15/1073/015 100 x 1 filmsko obložena tableta EU/1/15/1073/026 14 x 1 filmsko obložena tableta
Citric acid anhydrous (for pH-adjustment) Methyl parahydroxybenzoate (E218) Carmellose sodium 
6.1 Seznam pomožnih snovi natrijev citrat brezvodna citronska kislina (za uravnavanje pH) metilparahidroksibenzoat (E218) natrijev karmelozat sukraloza tekoči sorbitol glicerol (E422) aroma maline (propilenglikol 90 % - 98 %) prečiščena voda
Each ml of oral solution contains 10 mg brivaracetam. 
En ml peroralne raztopine vsebuje 10 mg brivaracetama.
In controlled studies, the carbamazepine epoxide plasma concentration increased by a mean of 37 %, 62 % and 98 % with little variability at brivaracetam doses of 50 mg/day, 100 mg/day and 200 mg/day respectively. 
62 % in 98 % pri odmerkih brivaracetama 50 mg/dan, 100 mg/dan in 200 mg/dan.
EU/1/15/1073/008 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/008 168 (3 pakiranja po 56) filmsko obloženih tablet
- 100 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide black (E172). 
- 100 mg filmsko obložene tablete: polivinilalkohol, titanov dioksid (E171), makrogol 3350, smukec, rumeni železov oksid (E172), črni železov oksid (E172).
- 75 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide red (E172), iron oxide black (E172). 
- 75 mg filmsko obložene tablete: polivinilalkohol, titanov dioksid (E171), makrogol 3350, smukec, rumeni železov oksid (E172), rdeči železov oksid (E172), črni železov oksid (E172).
Briviact 10 mg film-coated tablets Each film-coated tablet contains 10 mg brivaracetam. 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Briviact 10 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 10 mg brivaracetama.
EU/1/15/1073/009 14 film-coated tablets EU/1/15/1073/010 56 film-coated tablets EU/1/15/1073/011 100 x 1 film-coated tablet EU/1/15/1073/025 14 x 1 film-coated tablet 
EU/1/15/1073/009 14 filmsko obloženih tablet EU/1/15/1073/010 56 filmsko obloženih tablet EU/1/15/1073/011 100 x 1 filmsko obložena tableta EU/1/15/1073/025 14 x 1 filmsko obložena tableta
EU/1/15/1073/005 14 film-coated tablets EU/1/15/1073/006 56 film-coated tablets EU/1/15/1073/007 100 x 1 film-coated tablet EU/1/15/1073/024 14 x 1 film-coated tablet 
EU/1/15/1073/005 14 filmsko obloženih tablet EU/1/15/1073/006 56 filmsko obloženih tablet EU/1/15/1073/007 100 x 1 filmsko obložena tableta EU/1/15/1073/024 14 x 1 filmsko obložena tableta
EU/1/15/1073/020 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/020 168 (3 pakiranja po 56) filmsko obloženih tablet
EU/1/15/1073/001 14 film-coated tablets EU/1/15/1073/002 56 film-coated tablets EU/1/15/1073/003 100 x 1 film-coated tablet EU/1/15/1073/023 14 x 1 film-coated tablet 
EU/1/15/1073/001 14 filmsko obloženih tablet EU/1/15/1073/002 56 filmsko obloženih tablet EU/1/15/1073/003 100 x 1 filmsko obložena tableta EU/1/15/1073/023 14 x 1 filmsko obložena tableta
EU/1/15/1073/012 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/012 168 (3 pakiranja po 56) filmsko obloženih tablet
EU/1/15/1073/016 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/016 168 (3 pakiranja po 56) filmsko obloženih tablet
Brivaracetam oral solution can be diluted in water or juice shortly before swallowing and may be taken with or without food (see section 5.2). 
Peroralno raztopino brivaracetama lahko bolnik razredči z vodo ali sokom neposredno pred zaužitjem.
- 50 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide red (E172). 
- 50 mg filmsko obložene tablete: polivinilalkohol, titanov dioksid (E171), makrogol 3350, smukec, rumeni železov oksid (E172), rdeči železov oksid (E172).
- 25 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide black (E172). 
- 25 mg filmsko obložene tablete: polivinilalkohol, titanov dioksid (E171), makrogol 3350, smukec, rumeni železov oksid (E172), črni železov oksid (E172).
Topiramate 
Občasni
How to store Briviact 
Shranjevanje zdravila Briviact
75 mg twice a day. 
- Priporočeni odmerek je od 25 mg do 100 mg dvakrat na dan.
Some other medicines may influence the use of Grepid or vice versa. 
Nekatera druga zdravila lahko vplivajo na uporabo zdravila Grepid in obratno.
Date of first authorisation: 28 July 2009 Date of latest renewal: 11 April 2014 
Datum zadnjega podaljšanja dovoljenja za promet: 11. april 2014 10.
An occasional use of acetylsalicylic acid (not more than 1,000 mg in 24 hour period) should generally not cause a problem, but prolonged use in other circumstances should be discussed with your doctor. 
Priložnostna uporaba acetilsalicilne kisline (ne več kot 1.000 mg v kateremkoli 24 urnem obdobju) na splošno ne bi smela povzročati težav, vendar pa se morate o daljši uporabi v drugih okoliščinah posvetovati s svojim zdravnikom.
You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. 
O neželenih učinkih lahko poročate tudi neposredno na nacionalni center za poročanje, ki je naveden vPrilogi V. S tem, ko poročate o neželenih učinkih, lahko prispevate k zagotovitvi več informacij o varnosti tega zdravila.
- if you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6). 
- če ste alergični na klopidogrel ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
• if you have had a clot in an artery of your brain (ischaemic stroke) which occurred within the last seven days 
• če ste imeli strdek v možganski arteriji (ishemična kap), ki se je pojavil v zadnjih sedmih dneh;
You should take Grepid for as long as your doctor continues to prescribe it. 
Zdravilo Grepid morate jemati, vse dokler vam ga vaš zdravnik predpisuje.
• if you have had an allergy or reaction to any medicine used to treat your disease 
• če ste imeli alergijo ali alergijsko reakcijo na katero koli zdravilo, ki ste ga jemali
Their frequency is defined using the following conventions: common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data). 
Njihova pogostnost je navedena upoštevaje naslednji dogovor: pogosti (≥ 1/100, < 1/10), občasni (≥ 1/1.000, < 1/100), redki (≥ 1/10.000, < 1/1.000), zelo redki (< 1/10.000), neznani (ni mogoče oceniti iz razpoložljivih podatkov).
What Grepid is and what it is used for 
Kaj je zdravilo Grepid in za kaj ga uporabljamo
What you need to know before you take Grepid 
Kaj morate vedeti, preden boste vzeli zdravilo Grepid
Warnings and precautions If any of the situations mentioned below apply to you, you should tell your doctor before taking Grepid: 
Opozorila in previdnostni ukrepi Če katerokoli od spodaj navedenih stanj velja za vas, morate o tem obvestiti svojega zdravnika, preden boste vzeli zdravilo Grepid:
• Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 
• Preobčutljivost za zdravilno učinkovino ali katerokoli pomožno snov, navedeno v poglavju 6.1.
Other medicines and Grepid 
Druga zdravila in zdravilo Grepid
Then, the recommended dose is one 75 mg tablet of Grepid per day as described above. 
Nato je priporočeni odmerek ena 75-mg tableta na dan, kot je opisano zgoraj.
• if you are allergic to other thienopyridines (such as prasugrel, ticlopidine). 
• če ste alergični na druge tienopiridine (kot na primer prasugrel, tiklopidin)
You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Grepid and acetylsalicylic acid for this condition. 
Povedati so vam morali, da so "peroralni antikoagulanti" pri tej motnji učinkovitejši kot acetilsalicilna kislina ali kombinirana uporaba zdravila Grepid in acetilsalicilne kisline.
The most common side effect reported with Grepid is bleeding. 
Najpogostejši neželeni učinek o katerem so poročali z zdravilom Grepid je krvavitev.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V. 
Od zdravstvenih delavcev se zahteva, da poročajo o katerem koli domnevnem neželenem učinku zdravila na nacionalni center za poročanje, ki je naveden vPrilogi V.
10 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 50 film-coated tablets 84 film-coated tablets 90 film-coated tablets 100 film-coated tablets 
10 filmsko obloženih tablet 14 filmsko obloženih tablet 28 filmsko obloženih tablet 30 filmsko obloženih tablet 50 filmsko obloženih tablet 84 filmsko obloženih tablet 90 filmsko obloženih tablet 100 filmsko obloženih tablet
If you experience prolonged bleeding when taking Grepid If you cut or injure yourself, it may take longer than usual for bleeding to stop. 
Če doživite podaljšanje krvavitve v času jemanja zdravila Grepid Če se urežete ali poškodujete, lahko traja dlje kot običajno, da se vam krvavitev ustavi.
- if you suffer from severe liver disease. 
- če imate hudo jetrno obolenje.
- if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain. 
- če imate zdravstveno stanje, ki trenutno povzroča krvavitev, kot je rana na želodcu ali krvavitev v možganih.
• if you have kidney or liver disease 
• če imate ledvične ali jetrne bolezni.
The primary endpoint (the combined incidence of CV death, MI, stroke and BARC bleeding grade ≥ 2 at 12 months) was met showing non-inferiority. 
Primarni opazovani dogodek (kombinirana pojavnost SŽ smrti, MI, možganske kapi in krvavitev ≥ 2 po BARC po 12 mesecih) je bil dosežen in to dokazuje neinferiornost.
There have been a number of retrospective analyses, however, to evaluate this effect in patients treated with clopidogrel for whom there are genotyping results: CURE (n=2,721), CHARISMA (n=2,428), CLARITY-TIMI 28 (n=227), TRITON-TIMI 38 (n=1,477), and ACTIVE-A (n=601), as well as a number of published cohort studies. 
Opravljene pa so bile številne retrospektivne analize za oceno tega učinka pri bolnikih, zdravljenih s klopidogrelom, za katere so na voljo rezultati genotipizacije: CURE (n = 2721), CHARISMA (n = 2428), CLARITY-TIMI 28 (n = 227), TRITON-TIMI 38 (n = 1477) in ACTIVE-A (n = 601), poleg tega pa tudi številne objavljene kohortne študije.
Your doctor should have prescribed Grepid plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding. 
Zdravnik naj bi vam predpisal zdravilo Grepid skupaj z acetilsalicilno kislino, če ne morete prejemati "peroralnih antikoagulantov", ali če nimate tveganja za večjo krvavitev.
Each film-coated tablet contains 2.47 mg of lactose (as monohydrate). 
Ena filmsko obložena tableta vsebuje 2,47 mg laktoze (v obliki monohidrata).
If you have experienced severe chest pain (unstable angina or heart attack), you may be prescribed Grepid in combination with acetylsalicylic acid, a substance present in many medicines used to relieve pain and lower fever. 
Če ste doživeli hudo bolečino v prsih (nestabilna angina pektoris ali srčni napad), so vam morda predpisali zdravilo Grepid v kombinaciji z acetilsalicilno kislino, učinkovino, ki je prisotna v številnih zdravilih, ki se uporabljajo za lajšanje bolečine in zniževanje zvišane telesne temperature.
The active metabolite is formed mostly by CYP2C19 with contributions from several other CYP enzymes, including CYP1A2, CYP2B6 and CYP3A4. 
Aktivni presnovek nastane predvsem z delovanjem CYP2C19, k nastanku pa pripomorejo tudi drugi encimi CYP, vključno CYP1A2, CYP2B6 in CYP3A4.
Driving and using machines Grepid is unlikely to affect your ability to drive or to use machines. 
Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Grepid vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Grepid. 
Če menite, da se karkoli od navedenega nanaša na vas, ali če ste kakorkoli v dvomih, se posvetujte s svojim zdravnikom, preden boste vzeli zdravilo Grepid.
If you forget to take Grepid 
Če ste pozabili vzeti zdravilo Grepid
If HPR ≥ 46 units, the patients were escalated back to prasugrel 5 or 10 mg/d for 11.5 months; if HPR < 46 units, the patients continued on clopidogrel 75 mg/d for 11.5 months. 
Če je bil rezultat HPR ≥ 46 enot, je bila izvedena ponovna eskalacija na prasugrel 5 mg ali 10 mg/dan za 11,5 meseca; če je bil rezultat HPR < 46 enot, so bolniki nadaljevali zdravljenje s klopidogrelom 75 mg/dan v obdobju 11,5 meseca.
You have been prescribed Grepid to help prevent blood clots and reduce the risk of these severe events because: - you have a condition of hardening of arteries (also known as atherosclerosis), and - you have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or - You have experienced a severe type of chest pain known as ‘unstable angina' or ‘myocardial infarction' (heart attack). 
Zdravilo Grepid vam je predpisano za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate stanje otrdelih arterij (znano tudi kot ateroskleroza), in - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen, ali - ste doživeli hudo obliko bolečine v prsih, znano kot “nestabilna angina” ali “miokardni infarkt” (srčni napad).
What Grepid is and what it is used for What you need to know before you take Grepid How to take Grepid 
Kaj je zdravilo Grepid in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Grepid Kako jemati zdravilo Grepid Možni neželeni učinki